Zidovudine Capsule |
Azidothymidine Capsule; AZT Capsule; Compound S Capsule; Retrovir Capsule |
Clinical Trial: Study of SU011248 in Patients With Advanced Kidney Cancer
This study is not yet open for patient recruitment.
Verified by Pfizer December 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Renal Cell Carcinoma | Drug: SU011248 capsule | Phase II |
MedlinePlus related topics: Cancer; Kidney Cancer
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title: Phase II Study Of Single-Agent SU011248 In The Treatment Of Patients With Renal Cell Carcinoma
Secondary Outcomes: Safety, PK, PD, QOL
Expected Total Enrollment: 51
Study start: December 2005
Eligibility
Inclusion Criteria:
Exclusion Criteria:
Location and Contact Information
Pfizer CT.gov Call Center, Study Director, Pfizer
More Information
Last Updated: December 9, 2005
Record first received: November 14, 2005
ClinicalTrials.gov Identifier: NCT00254540
Health Authority: Japan: Ministry of Health, Labor and Welfare
ClinicalTrials.gov processed this record on 2006-01-10

Not Signed In -


